Paricalcitol may improve oxidative DNA damage on experimental amikacin-induced nephrotoxicity model

References

• Laurent G, Kishore BK, Tulkens PM. Aminoglycoside-induced renal phospholipidosis and nephrotoxicity. Biochem Pharmacol. 1990;40:2383–2392.
   PubMed Web of Science ®Google Scholar
• Ferriols-Lisart R, Alos-Alminana M. Effectiveness and safety of once-daily aminoglycosides: A meta-analysis. Am J Health Syst Pharm. 1996;53:1141–1150.
   PubMed Web of Science ®Google Scholar
• Drüeke TB. Which vitamin D derivative to prescribe for renal patients. Curr Opin Nephrol Hypertens. 2005;14:343–349.
   PubMed Web of Science ®Google Scholar
• Park JW, Bae EH, Kim IJ, et al. Paricalcitol attenuates cyclosporine-induced kidney injury in rats. Kidney Int. 2010;77:1076–1085.
   PubMed Web of Science ®Google Scholar
• Kuhlmann A, Haas CS, Gross ML, et al. 1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. Am J Physiol Renal Physiol. 2004;286:526–533.
   PubMed Web of Science ®Google Scholar
• Tan X, Li Y, Liu Y. Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol. 2006;17:3382–3393.
   PubMed Web of Science ®Google Scholar
• Mizobuchi M, Morrissey J, Finch JL, et al. Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats. J Am Soc Nephrol. 2007;18:1796–1806.
   PubMed Web of Science ®Google Scholar
• Ari E, Kedrah AE, Alahdab Y, et al. Antioxidant and renoprotective effects of paricalcitol on experimental contrast-induced nephropathy model. Br J Radiol. 2012;85:1038–1043.
   PubMed Web of Science ®Google Scholar
• Eren Z, Gunal MY, Bakir EA, et al. Effects of paricalcitol and aliskiren combination therapy on experimental diabetic nephropathy model in rats. Kidney Blood Press Res. 2014;39:581–590.
   PubMed Web of Science ®Google Scholar
• Fryer RM, Rakestraw PA, Nakane M, et al. Differential inhibition of renin mRNA expression by paricalcitol and calcitriol in C57/BL6 mice. Nephron Physiol. 2007;106:76–81.
   Google Scholar
• Husain K, Suarez E, Isidro A, Ferder L. Effects of paricalcitol and enalapril on atherosclerotic injury in Mouse aortas. Am J Nephrol. 2010;32:296–304.
   PubMed Web of Science ®Google Scholar
• Ulusoy S, Ozkan G, Ersoz S, et al. The effect of grape seed proanthocyanidin extract in preventing amikacin-induced nephropathy. Ren Fail. 2012;34:227–234.
   PubMed Web of Science ®Google Scholar
• Parlakpinar H, Ozer MK, Ucar M, et al. Protective effects of caffeic acid phenethyl ester (CAPE) on amikacin-induced nephrotoxicity in rats. Cell Biochem Funct. 2006;24:363–367.
   PubMed Web of Science ®Google Scholar
• Kitada M, Takeda A, Nagai T, Ito H, Kanasaki K, Koya D. Dietary restriction ameliorates diabetic nephropathy through anti-inflammatory effects and regulation of the autophagy via restoration of Sirt1 in diabetic Wistar fatty (fa/fa) rats: A model of type 2 diabetes. Exp Diabetes Res. 2011;2011:908185.
   PubMedGoogle Scholar
• Khoschsorur GA, Winklhofer-Roob BM, Rabl H, et al. Evaluation of a sensitive HPLC method for the determination of malondialdehyde and application of the method to different biological materials. Chromatographia. 2000;52:181–184.
   Web of Science ®Google Scholar
• Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
   PubMed Web of Science ®Google Scholar
• Shigenaga MK, Aboujaoude EN, Chen Q, Ames BN. Assays of oxidative DNA damage biomarkers 8-oxo-2'-deoxyguanosine and 8-oxoguanine in nuclear DNA and biological fluids by high-performance liquid chromatography with electrochemical detection. Methods Enzymol. 1994;234:16–33.
   PubMed Web of Science ®Google Scholar
• Armstrong D. Free radical and antioxidant protocols: Introduction. Methods Mol Biol. 1998;108:5–8.
   Google Scholar
• Beutler E. The preparation of red cells for assay. In: Beutler E, ed. Red Cell Metabolism: A Manual of Biochemical Methods. New York, NY: Grune and Straton Company; 1975:8–18.
   Google Scholar
• Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34:497–500.
   PubMed Web of Science ®Google Scholar
• Solez K, Kramer EC, Fox JA, Heptinstall RH. Medullary plasma flow and intravascular leukocyte accumulation in acute renal failure. Kidney Int. 1974;6:24–37.
   PubMed Web of Science ®Google Scholar
• Rosenberger C, Heyman SN, Rosen S, et al. Up-regulation of HIF in experimental acute renal failure: Evidence for a protective transcriptional response to hypoxia. Kidney Int. 2005;67:531–542.
   PubMed Web of Science ®Google Scholar
• Walker R. Aminoglycoside nephrotoxicity: Recent developments. N Z Med J. 1994;107:54–55.
   PubMed Web of Science ®Google Scholar
• Swan SK. Aminoglycoside nephrotoxicity. Semin Nephrol. 1997;17:27–33.
   PubMed Web of Science ®Google Scholar
• Kose E, Beytur A, Dogan Z, et al. The effects of montelukast against amikacin-induced acute renal damage. Eur Rev Med Pharmacol Sci. 2012;16:503–511.
   PubMed Web of Science ®Google Scholar
• Asci H, Saygin M, Cankara FN, et al. The impact of alpha-lipoic acid on amikacin-induced nephrotoxicity. Ren Fail. 2015;37:117–121.
   PubMed Web of Science ®Google Scholar
• Ames BN. Endogenous oxidative DNA damage, aging, and cancer. Free Radic Res Commun. 1989;7:121–128.
   PubMedGoogle Scholar
• Datta SR, Dudek H, Tao X, et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 1997;91:231–241.
   PubMed Web of Science ®Google Scholar
• Chen YC, Chen CH, Hsu YH, et al. Leptin reduces gentamicin-induced apoptosis in rat renal tubular cells via the PI3K-Akt signaling pathway. Eur J Pharmacol. 2011;658:213–218.
   PubMed Web of Science ®Google Scholar
• Lee KE, Kim EY, Kim CS, et al. Macrophage-stimulating protein attenuates hydrogen peroxide-induced apoptosis in human renal HK-2 cells. Eur J Pharmacol. 2013;715:304–311.
   PubMed Web of Science ®Google Scholar
• Suh SH, Lee KE, Park JW, et al. Antiapoptotic effect of paricalcitol in gentamicin-induced kidney injury. Korean J Physiol Pharmacol. 2013;17:435–440.
   PubMed Web of Science ®Google Scholar
• Izquierdo MJ, Cavia M, Muniz P, et al. Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients. BMC Nephrol. 2012;13:159
   PubMed Web of Science ®Google Scholar
• Freundlich M, Quiroz Y, Zhang Z, et al. Suppression of renin-angiotensin gene expression in the kidney by paricalcitol. Kidney Int. 2008;74:1394–1402.
   PubMed Web of Science ®Google Scholar
• Kang YS, Park YG, Kim BK, et al. Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes. J Mol Endocrinol. 2006;36:377–388.
   PubMed Web of Science ®Google Scholar
• Jia P, Teng J, Zou J, et al. Intermittent exposure to xenon protects against gentamicin-induced nephrotoxicity. PLoS One. 2013;8:e64329.
   PubMed Web of Science ®Google Scholar